Human transferrin receptor gene as a marker gene for MR imaging.

PURPOSE To quantitate and characterize the expression of an engineered human transferrin receptor (ETR) as a marker gene by using magnetic resonance (MR) imaging. MATERIALS AND METHODS Rat gliosarcoma 9L cells stably expressing ETR (ETR+) were used, with nontransfected (ETR-) cells serving as controls. A conjugate of transferrin and monocrystalline iron oxide (Tf-MION) nanoparticles was synthesized to probe for the activity of ETR. Accumulation of Tf-MION was examined by using cell internalization in culture and MR (n = 6) and nuclear (n = 4) imaging in a mouse model with ETR+ and ETR- tumors implanted in the opposite flanks. Autoradiographic and histopathologic results were correlated with MR findings. RESULTS Tf-MION was internalized by ETR+ cells at 37 degrees C but not at 4 degrees C. Rhodamine-labeled Tf-MION and fluorescein-labeled antibody to ETR colocalized in small vesicle-like structures in the cytoplasm. Both findings were consistent with accumulation by the receptor-mediated endocytosis mechanism of ETR. Compared with ETR- tumors, ETR+ tumors accumulated more Tf-MION and had higher signal intensity on T1-weighted MR images and lower signal intensity on T2-weighted images. Autoradiographic findings showed a spatial correlation between MR signal intensity and TF-MION accumulation. CONCLUSION ETR+ tumors internalize the MR imaging probe through the action of transferrin receptor in amounts that can be detected with MR imaging.

[1]  R Weissleder,et al.  Improvement of MRI probes to allow efficient detection of gene expression. , 2000, Bioconjugate chemistry.

[2]  R Weissleder,et al.  In vivo imaging of proteolytic enzyme activity using a novel molecular reporter. , 2000, Cancer research.

[3]  P. Opolon,et al.  Adenovirus-mediated transfer of the thyroid sodium/iodide symporter gene into tumors for a targeted radiotherapy. , 2000, Cancer research.

[4]  C. Schmutzler,et al.  Innovative strategies for the treatment of thyroid cancer. , 2000, European journal of endocrinology.

[5]  X. Breakefield,et al.  Prodrug activation enzymes in cancer gene therapy , 2000, The journal of gene medicine.

[6]  J. Mountz,et al.  Noninvasive monitoring of gene transfer using a reporter receptor imaged with a high-affinity peptide radiolabeled with 99mTc or 188Re. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[7]  Ralph Weissleder,et al.  Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells , 2000, Nature Biotechnology.

[8]  M. Black,et al.  A mutant herpes simplex virus type 1 thymidine kinase reporter gene shows improved sensitivity for imaging reporter gene expression with positron emission tomography. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[9]  Anna Moore,et al.  In vivo magnetic resonance imaging of transgene expression , 2000, Nature Medicine.

[10]  Scott E. Fraser,et al.  In vivo visualization of gene expression using magnetic resonance imaging , 2000, Nature Biotechnology.

[11]  R. Blasberg,et al.  Imaging adenoviral-mediated herpes virus thymidine kinase gene transfer and expression in vivo. , 1999, Cancer research.

[12]  R. Weissleder.  Molecular imaging: exploring the next frontier. , 1999, Radiology.

[13]  Johannes Meller,et al.  Scintigraphy with 99mTc-pertechnetate in the evaluation of functional thyroidal autonomy. , 1999, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.

[14]  Blasberg Rg,et al.  Herpes simplex virus thymidine kinase as a marker/reporter gene for PET imaging of gene therapy. , 1999 .

[15]  J. Montgomery,et al.  Gene therapy of cancer: activation of nucleoside prodrugs with E. coli purine nucleoside phosphorylase. , 1999, Nucleosides & nucleotides.

[16]  M. Mayo,et al.  In vivo localization of [(111)In]-DTPA-D-Phe1-octreotide to human ovarian tumor xenografts induced to express the somatostatin receptor subtype 2 using an adenoviral vector. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[17]  R. Mandell,et al.  Radioisotope concentrator gene therapy using the sodium/iodide symporter gene. , 1999, Cancer research.

[18]  J. Humm,et al.  Imaging herpes virus thymidine kinase gene transfer and expression by positron emission tomography. , 1998, Cancer research.

[19]  R Weissleder,et al.  Measuring transferrin receptor gene expression by NMR imaging. , 1998, Biochimica et biophysica acta.

[20]  R Weissleder,et al.  The development of in vivo imaging systems to study gene expression. , 1998, Trends in biotechnology.

[21]  D. Curiel,et al.  Tumor localization of a radiolabeled bombesin analogue in mice bearing human ovarian tumors induced to express the gastrin‐releasing peptide receptor by an adenoviral vector , 1997, Cancer.

[22]  Masafumi Oshiro,et al.  Visualizing Gene Expression in Living Mammals Using a Bioluminescent Reporter , 1997, Photochemistry and photobiology.

[23]  R Weissleder,et al.  MR imaging and scintigraphy of gene expression through melanin induction. , 1997, Radiology.

[24]  L. Wiebe,et al.  Non‐invasive scintigraphic monitoring of gene expression in a HSV‐1 thymidine kinase gene therapy model , 1997, Nuclear medicine communications.

[25]  L I Wiebe,et al.  Radiopharmaceuticals to monitor gene transfer. , 1997, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.

[26]  Z. Ram,et al.  Mechanism of ‘bystander effect’ killing in the herpes simplex thymidine kinase gene therapy model of cancer treatment , 1997, Gene Therapy.

[27]  R Weissleder,et al.  Magnetically labeled cells can be detected by MR imaging , 1997, Journal of magnetic resonance imaging : JMRI.

[28]  L. Josephson,et al.  Use of AMI-227 as an oral MR contrast agent. , 1994, Magnetic resonance imaging.

[29]  R Weissleder,et al.  Monocrystalline iron oxide nanocompounds (MION): Physicochemical properties , 1993, Magnetic resonance in medicine.

[30]  M. Cotten,et al.  Receptor-mediated transport of DNA into eukaryotic cells. , 1993, Methods in enzymology.

[31]  Lee Josephson,et al.  The magnetic properties of some materials affecting MR images , 1991, Magnetic resonance in medicine.

[32]  C. Hopkins,et al.  Transferrin receptors promote the formation of clathrin lattices , 1991, Cell.

[33]  T J Brady,et al.  MR receptor imaging: ultrasmall iron oxide particles targeted to asialoglycoprotein receptors. , 1990, AJR. American journal of roentgenology.

[34]  S. White,et al.  Combinations of anti-transferrin receptor monoclonal antibodies inhibit human tumor cell growth in vitro and in vivo: evidence for synergistic antiproliferative effects. , 1990, Cancer research.

[35]  H. Bengele,et al.  A functionalized superparamagnetic iron oxide colloid as a receptor directed MR contrast agent. , 1990, Magnetic resonance imaging.

[36]  I. Trowbridge,et al.  Transferrin receptors: structure and function. , 1984, Biochemical pharmacology.

[37]  R. Brasch,et al.  Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent. , 1984, AJR. American journal of roentgenology.

[38]  C. Hopkins,et al.  Internalization and processing of transferrin and the transferrin receptor in human carcinoma A431 cells , 1983, The Journal of cell biology.

[39]  P. Weigel,et al.  The surface content of asialoglycoprotein receptors on isolated hepatocytes is reversibly modulated by changes in temperature. , 1983, The Journal of biological chemistry.

[40]  P. Weigel,et al.  Temperature dependence of endocytosis mediated by the asialoglycoprotein receptor in isolated rat hepatocytes. Evidence for two potentially rate-limiting steps. , 1981, The Journal of biological chemistry.

[41]  Joseph L. Goldstein,et al.  Coated pits, coated vesicles, and receptor-mediated endocytosis , 1979, Nature.

[42]  V. Levin,et al.  Factors influencing the survival of rat brain tumor cells after in vitro treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea. , 1975, Cancer research.